Epithelial Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Epithelial Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: The Real World Efficacy and Safety of Niraparib in Korean Women With Primary and Recurrent Epithelial Ovarian Cancer
Real-world data assess the effectiveness and safety of niraparib in Korean women with primary and recurrent epithelial ovarian cancer. The s…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer [Phase 3]
Phase 3 trial recruitment is ongoing for AZD5335 versus Mirvetuximab Soravtansine in FRα-high epithelial ovarian cancer and AZD5335 versus c…
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer [Phase 2]
A Phase 2 trial of RC88 in platinum-resistant recurrent epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer has …
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers [Phase 1]
Phase 1b study evaluating SL-172154 in combination with other agents in platinum-resistant ovarian, fallopian tube, and primary peritoneal c…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. [Phase 2]
A Phase 2 clinical study of TORL-1-23 is evaluating its activity in platinum-resistant ovarian cancer. The trial is currently recruiting acr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Phase I Study of Autologous CAR T-Cells Targeting the B7-H3 Antigen in Recurrent Epithelial Ovarian [Phase 1]
Phase I study evaluating autologous CAR T-cells targeting B7-H3 in recurrent epithelial ovarian cancer has results posted.
-
CLINICAL_TRIALS other · 2025-11-19Clinical Trial Update: Study of AVZO-021 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update shows AVZO-021 is in Phase 1/2 for advanced solid tumors including HR+/HER2- breast cancer and several gynecologi…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer [NA]
Clinical trial investigating whether hepato-celiac lymphadenectomy affects survival in primary or relapsed epithelial ovarian cancer and rel…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: NEOadjuvant Dendritic Cell Vaccination for Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a neoantigen-based dendritic cell vaccine (NEOadjuvant) for ovarian cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: The Immune Landscape of Epithelial Ovarian Cancer
This clinical trial update describes an ongoing study investigating the immune landscape of epithelial ovarian cancer, which is currently re…
-
CLINICAL_TRIALS other · 2025-11-18Clinical Trial Update: Platino-resistance in Ovarian Cancer [NA]
This clinical trial update indicates a study addressing platinum resistance in epithelial ovarian cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors [Phase 1]
This Phase 1 trial update reports on the combination of MGC018 and MGD019 in participants with advanced solid tumors, including castration-r…
-
CLINICAL_TRIALS withdrawal · 2025-09-23Clinical Trial Update: REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1 [Phase 2, Phase 3]
The REFRaME-O1 trial evaluating Luveltamab Tazevibulin versus investigator's choice chemotherapy for FOLR1-expressing ovarian cancer and rel…
-
CLINICAL_TRIALS research · 2025-09-12Clinical Trial Update: Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating secondary cytoreductive surgery after chemotherapy for recurrent epithelial ovarian cancer is currently …
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Etoposide Capsules Combined With Bevacizumab and Iparomlimab and Tuvonralimab in the Treatment of Platinum Resistant or Platinum Refractory Ovarian Cancer [Phase 2]
Phase 2 clinical trial update examining etoposide capsules plus bevacizumab, iparomlimab, and tuvonralimab for platinum-resistant or platinu…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating safety and tolerability of BCA101 as monotherapy and in combination in EGFR-driven advanced solid tumors. The trial…
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Genetic Testing Decision Aid [NA]
This clinical trial update reports a genetic testing decision aid study sponsored by Massachusetts General Hospital. It targets patients wit…
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Phase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid Tumors [Phase 1]
Phase 1, first-in-human dose-finding and expansion study of XmAb808 in combination with pembrolizumab in advanced solid tumors; the trial ha…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: CT-95 in Advanced Cancers Associated With Mesothelin Expression [Phase 1]
Phase 1 trial CT-95 for mesothelin-expressing tumors is currently recruiting across multiple indications, including epithelial ovarian cance…
-
CLINICAL_TRIALS research · 2025-07-30Clinical Trial Update: AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer [Phase 1]
AB-1015 is an integrated circuit T cell therapy being studied in a Phase 1 trial for platinum-resistant epithelial ovarian cancer; the trial…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: Centralization and Oncologic Outcomes in Ovarian Cancer
Clinical trial update on centralization and oncologic outcomes in ovarian cancer; the trial is currently active but not recruiting.
-
FDA label_change · 2025-07-14FDA Approved: ELAHERE — Supplemental Application (ImmunoGen, Inc.)
The FDA approved a supplemental application for ELAHERE (mirvetuximab soravtansine) from ImmunoGen, Inc., updating the product labeling.
-
CLINICAL_TRIALS trial_result · 2025-07-09Clinical Trial Update: Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors [Phase 1, Phase 2]
A pharmacokinetic study evaluating the combination of lurbinectedin and irinotecan in selected solid tumors has completed (Phase 1/Phase 2).
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: CART-meso in Mesothelin Expressing Cancers [Phase 1]
Phase 1 update on CART-meso, a mesothelin-targeted CAR T-cell therapy, tested in mesothelin-expressing cancers including metastatic pancreat…
-
CLINICAL_TRIALS trial_result · 2025-06-24Clinical Trial Update: A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy [Phase 3]
A Phase 3 trial update reports results for maintenance therapy with rucaparib and nivolumab in ovarian cancer patients who responded to fron…